Common side effects of ORSERDU™ include musculoskeletal pain, nausea, fatigue, and increases in cholesterol and liver enzymes.  

Side Effects of ORSERDU™

The most frequently reported side effects of ORSERDU™ are musculoskeletal pain, nausea, fatigue, and dyslipidemia, including elevated cholesterol and triglycerides. Other common adverse reactions include vomiting, increased liver enzymes (AST, ALT), and decreased hemoglobin. Gastrointestinal disturbances such as decreased appetite, abdominal pain, diarrhea, and constipation have also been noted. Additionally, headache, hot flush, and dyspepsia are reported. These side effects may require dose modifications or interruptions based on severity. Patients should be regularly monitored for these reactions, particularly liver function and lipid levels.

Elacestrant(Orserdu)
ORSERDU™ is indicated for postmenopausal women or adult men with ER-positive, HER2-negative, ESR1-mutated advanced or metastatic breast cancer.
RELATED ARTICLES
/ 0
0 in total
Contact Medical Consultant
Global Drug Search
Clinical recruitment
overseas medical treatment
Remote consultation
Note: Our medical consultant will contact you as soon as possible. We promise to strictly protect your privacy.
Click to submit medical consultant
Contact Us
Mailbox:Info@Lucius.La
Welcome To Consult
Ucius Pharmaceuticals (Lao) Co.,Ltd All Rights Reserved